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The iron chelating agent deferoxamine was studied in an animal model as post-resuscitation 
therapy to prevent late deaths and brain damage following total circulatory arrest and 
resuscitation. Cardio-respiratory arrest was induced by injection of cold, 1% KC1 into the left 
ventricles of ketamine anesthetized rats pretreated with succinylcholine chloride, and by 
discontinuation of positive pressure ventilation. CPR was begun after six minutes, and animals 
with return of spontaneous circulation were entered into the study. Within five minutes after 
return of spontaneous circulation, treated animals received deferoxamine (50 mg/kg, IV). At ten 
days, 16 of 25 (64%) of treated animals had survived without neurologic deficit, compared to 
nine of 25 (36%) of controls (chi square = 3.92, P < .05). Chelation of intracellular iron by 
deferoxamine may have prevented free-radical-mediated reactions that led to late deaths in 
control animals.  
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Late deaths following initially successful CPR may be related to specific and preventable 
phenomena that occur during the reperfusion period [1-4]. Indeed, a large proportion of the total 
injury seen after five-minute to 15- minute periods of circulatory arrest may develop during the 
reperfusion phase, due to 1) the no-reflow phenomenon [5], in which cerebral vascular resistance 
rises during reperfusion after ischemic anoxia, decreasing perfusion to areas of the brain; 2) 
continued calcium influx through cell membranes damaged during anoxia, leading to 
intracellular calcium intoxication during reperfusion [2, 3, 6, 7]; or 3) production of oxidative 
free radicals, causing progressive lipid peroxidation in cell membrane systems, particularly in the 
lipid-rich brain [l, 3, 8]. If, in fact, irreversible damage to the brain and other organs by such 
mechanisms occurs during the period of reperfusion rather than during the period of anoxia, the 
corresponding pathophysiologic entity, "reperfusion injury" ,may be treatable as part of advanced 
cardiac life support (ACLS). 
 
Deferoxamine is a clinically available iron-binding agent with an extremely high affinity for 
iron. It is water soluble, yet crosses the blood brain barrier, and does not interfere significantly 
with the oxygen transport function of hemoglobin [9]. Blaine C. White [3] recently proposed that 
free iron ions liberated from intracellular stores during ischemic anoxia may play a major role in 
the genesis of reperfusion injury by oxidative free radicals. Our study was designed as a 




MATERIALS AND METHODS 
 
The rat circulatory arrest model used has been described previously [10]. Fifty male Wistar rats, 
each weighing between 350 and 450 g, were sorted randomly into experimental and control 
groups of 25 animals each. Each rat was anesthetized with ketamine 160 mg/kg intraperitoneally 
(IP). Succinylcholine chloride 1.5 mg/kg, IP was given to prevent gasping at the onset of 
circulatory arrest. A midline tracheostomy was performed, and jet ventilation with room air at 40 
breaths per minute was provided through a teflon cannula by a Physiograph
®
 small animal 
respirator (Narco Bio-Systems, Houston, Texas). 
 
Cardiorespiratory arrest was induced in each rat by discontinuation of jet ventilation, 
percutaneous intracardiac injection of 0.8 mL cold 1% KCl cardioplegic solution, and steady 
digital compression of the thorax [10]. The ECG was monitored throughout the arrest and 
immediate post-resuscitation periods. The cardio-respiratory arrest was maintained for six 
minutes, after which resuscitation was accomplished by interposed abdominal compression- 
cardiopulmonary resuscitation (IAC-CPR) and jet ventilation with room air at 70 breaths per 




Animals in which sinus rhythm and a palpable heartbeat returned were entered into either the 
experimental or control groups. Rats in the experimental group were given deferoxamine (50 
mg/kg) through an external jugular vein during a one-minute period. (Deferoxamine (Desferal
®
) 
was obtained as a powder from CIBA Pharmaceutical Company, Summit, New Jersey, and was 
dissolved freshly in de-ionized water to a concentration of 50 mg/mL.) The control rats were 
given no drug.  
 
All rats then were placed on a 37 
o
C heating pad and given 5 mL each 5% dextrose solution and 
lactated Ringer's solution by subcutaneous injection to maintain hydration. The rats were weaned 
from the respirator by gradual decrease in the ventilation frequency to 20 breaths per minute 
during a period of one to two hours. When vigorous spontaneous respirations were observed, jet 
ventilation was discontinued, the trachea was extubated, and the neck wound was closed with 
silk sutures. 
 
Thereafter the rats were returned to individual cages where they were observed daily for ten 
days, during which no further intensive care was provided. Neurologic deficit score was 
measured at 24 hours after arrest and daily thereafter for seven days, or until death, by a 
modification of the method of Safar and coworkers [11] as adapted for rats by deGaravilla [12]. 
The number of animals surviving was recorded at 12 hours, 24 hours, and daily for ten days. Chi-
square statistics were calculated to test the null hypothesis that at each recording time the 





Most resuscitated rats could be weaned from the ventilator within one to two hours after 
resuscitation. At three to six hours after arrest, survivors in both groups were awake but ataxic, 
with depressed responsiveness to touch, painful stimuli, and air jets.  
 
Deaths during the first 12 hours were associated with failure to recover from anesthesia or to be 
weaned from the ventilator. At 36 hours, however, all survivors were awake and responsive, 
without localized neurologic deficit. Although the mean neurologic deficit score of survivors at 
36 hours was zero in both treated and control groups, animals destined to die in the second 
through fourth days after arrest huddled in the comers of their cages and became progressively 
anorexic, dehydrated, and less well groomed.  In contrast, those destined to survive long-term 
remained alert, active, and well groomed, and they began to eat and drink normally.  
 
At ten days after arrest, surviving animals in both treated and control groups were without 
neurologic deficit. The incidence of survival in the treated group, however, was significantly 
greater than in the control group at days 7 through 10 (chi square = 3.92; 0.01 < P < 0.05). At the 
end of the ten-day period, survival rates for the control and experimental groups were 36% and 








FIGURE. Survival as a function of time after cardiac arrest and resuscitation in 
deferoxamine-treated versus control rats. The deferoxamine dose was 50 mg/kg IV, 





Our study found a statistically significant increase in long-term survival following seven-minute 
to ten-minute periods of total circulatory arrest and CPR in a whole animal model of ischemia 
and reperfusion in rats. To place these results in perspective, one should consider that since the 
discovery of modem CPR methods in the 1960s, the only interventions shown to produce 
comparable improvement in long-term survival in any animal model or in human beings have 
been the use of adrenergic drugs such as epinephrine [13, 14] and the use of earlier electrical 
defibrillation in cases of ventricular fibrillation [15, 16]. 
 
It is of particular interest that survival curves separate only after the second day. This 
observation, together with the differing behavior of survivors and non-survivors during the 
second through fourth days, is consistent with the possibility of gradually developing tissue 
injury during the first few days after reperfusion. Such a time course is consistent with that of 
ongoing injury by iron-catalyzed lipid peroxidation. Recent unpublished computer simulations of 
the kinetics of lipid peroxidation reactions suggest that such reactions may continue and even 
accelerate for hours to days after their initiation (Charles F Babbs, MD, unpublished data). Thus 
 5 
 
the time course of the survival curves is consistent with the type of smoldering oxidative 
reactions that we have proposed as a biochemical mechanism for post-resuscitation brain injury 
[4]. 
 
Our study, however, is quite limited as a test of the lipid peroxidation hypothesis. The task 
remains to search for biochemical evidence of lipid peroxidation in this model and the 
diminution of lipid peroxidation in deferoxamine-treated animals. Further, it will be important in 
the future to test control animals treated with iron-loaded deferoxamine (i.e., ferioxamine) to 






Our study clearly is a preliminary one, and we do not recommend the clinical use of iron 
chelators until their mechanism of action and safety have been established in further animal 
studies. Nevertheless, because deferoxamine administered after return of spontaneous circulation 
significantly improved long-term survival, the results are consistent with the hypothesis that a 
substantial amount of preventable tissue damage, leading to death, was occurring in the control 
animals during the reperfusion phase, and that the mechanism of damage involves iron ions.  
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